UK’s MHRA Revokes Authorization For Novartis’ Sickle Cell Drug

UK’s MHRA Revokes Authorization For Novartis’ Sickle Cell Drug

The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom announced on Wednesday the revocation of the conditional…